Market Research Industry Today

NGS Kits Market

NGS Kits Market was valued USD 6.26 Billion in 2023 and projected to reach USD 19.1 Billion by 2030, growing at a CAGR of 17.28% during the forecast period of 2023-2030 - published by MarketDigits
Published 12 November 2024

According to a research report "NGS Kits Market”, by Workflow (Library Preparation, Cluster Generation, Sequencing Reagents/Kits), Sequencing Type (WES and WGS, Targeted Sequencing, Long-Read Sequencing, Others), Usage (Clinical, Research), Application (Oncology, Rare Diseases, Genetic Disorders, Reproductive Health, Others), End-User (Academic and Research Institutions, Pharmaceutical and Biotechnology Companies, Clinical and Diagnostic Laboratories, Others), & Region - Global Forecast to 2030.

Download the Sample - https://www.marketdigits.com/request/sample/3610

  • 160 - Market Data Tables 
  • 61 - List of Figures
  • 210 - Pages

Market Overview: The Next-Generation Sequencing (NGS) kit market is a dynamic and rapidly evolving sector within the biotechnology industry, driven by advancements in genomics research and personalized medicine. These kits encompass a range of essential components, including library preparation, sequencing reagents, and analysis tools, enabling high-throughput DNA and RNA sequencing. The market is characterized by intense competition among key players, with a focus on innovation, cost-effectiveness, and user-friendly solutions. Growing demand for NGS applications in fields such as oncology, infectious diseases, and agriculture contributes to the market's expansion. As technology continues to improve and sequencing costs decrease, the NGS kit market is expected to witness sustained growth, facilitating breakthroughs in understanding genetic variations and supporting clinical diagnostics.

Market Dynamics

Drivers:

  • Rising Demand for Personalized Medicine
  • Growing Awareness and Acceptance of NGS
  • The growing adoption of NGS in clinical research

Opportunities:

  • Development of new NGS applications
  • Increasing competition and innovation
  • Technological advancements in NGS workflow

The NGS Kits Market is dominated by North America.

North America boasts a well-established and advanced healthcare infrastructure, with numerous hospitals, clinics, and research institutions equipped with the latest NGS technologies. This extensive infrastructure provides a strong foundation for the adoption and utilization of NGS kits in various healthcare settings. North America is home to a world-class research base, with leading universities, research institutes, and pharmaceutical companies actively engaged in NGS research and development. This strong research base drives innovation in NGS technologies and contributes to the development of new NGS kits tailored to specific research needs. North America has one of the highest healthcare spending rates globally, providing ample funding for NGS research and the adoption of NGS kits in clinical settings. This significant financial investment fuels the growth of the NGS kit market.

Illumina, a leading developer of NGS technologies, unveiled its NovaSeq™ X Plus, a high-throughput NGS system designed to deliver exceptional performance and flexibility. This powerful system boasts a significant increase in sequencing capacity, enabling researchers to generate more data in less time. Additionally, the NovaSeq™ X Plus offers a wider range of sequencing applications, making it a versatile tool for various research and clinical needs. This type of recent development of NGS kit market increases growth in the north America.

The Asia-Pacific region is the fastest-growing market for NGS Kits Market. The region's increasing healthcare spending, expanding research activities, and growing awareness of personalized medicine are driving the market's growth. China, India, and Japan are the major markets for NGS kits in the Asia-Pacific region. This rapid growth is driven by several factors, including increasing healthcare spending, expanding research activities, and growing awareness of personalized medicine. China, India, and Japan are the major markets for NGS kits in the Asia-Pacific region. As the healthcare infrastructure and research capabilities in these countries continue to develop, the demand for NGS kits is expected to grow even further.

Key Players highlighted in the report:

  • Agilent Technologies
  • BioDynami
  • Creative Biogene
  • New England Biolabs
  • PerkinElmer
  • Thermo Fisher Scientific
  • Abcam
  • Devyser
  • Diagenode
  • Lexogen
  • Roche
  • Tecan
  • Enzynomics
  • MGI
  • Takara Bio
  • TIANGEN Biotech
  • TransGen Biotech and Vazyme
  • Qiagen
  • PerkinElmer

Direct Buy @ https://www.marketdigits.com/checkout/3610

Segmentations Analysis of NGS Kits Market: -

  • By Workflow
  • By Sequencing Type
  • By Usage
  • By Application
  • By End-User
  • By Region

About us:

MarketDigits is one of the leading business research and consulting companies that helps clients to tap new and emerging opportunities and revenue areas, thereby assisting them in operational and strategic decision-making. We at MarketDigits believe that a market is a small place and an interface between the supplier and the consumer, thus our focus remains mainly on business research that includes the entire value chain and not only the markets.

Contact Us: Email: sales@marketdigits.com

Other Industry News

Ready to start publishing

Sign Up today!